跳至主要内容
临床试验/DRKS00014582
DRKS00014582进行中(未招募)未知

Prospective, multicenter, comparative study of recurrence-free survival after liver transplantation in two tumor stage-defined groups (UNOS T2 versus Milan-out / UCSF-in) of patients with hepatocellular carcinoma (HCC) in cirrhosis and locoregional therapy for bridging the waiting period - TOM

niversitätsklinikum Schleswig-Holstein (UKSH), Campus Kiel0 个研究点目标入组 14 人开始时间: 2020年2月12日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
14

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • •Patients with HCC in cirrhosis according to current guidelines
  • •- Patients with HCC in cirrhosis in the tumor stage UNOS T2 or patients with HCC in cirrhosis outside Milan and within the UCSF criteria
  • •- Age from 18 years
  • •- Decision of the transplant conference with approval for liver transplantation
  • •- Decision of the tumor conference with diagnosis and tumor stage
  • •- Listing at Eurotransplant

排除标准

  • •- Patients with extrahepatic HCC manifestation (N + M +)
  • •- patients with macrovascular invasion of HCC (V2)
  • •- Existing pregnancy

研究者

发起方
niversitätsklinikum Schleswig-Holstein (UKSH), Campus Kiel

相似试验

Prospective, multicenter, comparative study of... | 临床试验